Melbourne researchers have identified a protein responsible for preserving the antibody-producing cells that lead to long-term immunity after infection or vaccination.
Australian researchers have identified a protein responsible for preserving the antibody-producing cells that lead to long-term immunity after infection or vaccination. Professor David Tarlinton (left), Dr Kim Good-Jacobson (right) and colleagues from Melbourne's Walter and Eliza Hall Institute discovered the presence of a protein called Myb was essential for antibody-producing plasma cells to migrate into bone marrow, preserving them for many years or even decades. Their findings were published in the Journal of Experimental Medicine. Photo courtesy of Walter and Eliza Hall Institute
Melbourne researchers have identified a protein responsible for preserving the antibody-producing cells that lead to long-term immunity after infection or vaccination.
Dr. Kim Good-Jacobson, professor David Tarlinton and colleagues from the Walter and Eliza Hall Institute discovered the presence of a protein called Myb was essential for antibody-producing plasma cells to migrate into bone marrow, preserving them for many years or even decades. Their findings were published in the Journal of Experimental Medicine.
Good-Jacobson says plasma cells were created when the immune system was exposed to pathogens such as viruses or bacteria. "When our immune system encounters a new pathogen, it can create plasma cells that secrete antibodies to specifically prevent future infections, generating immunity," she says. "Our bone marrow is like a long-term storage facility for plasma cells, allowing them to continue producing antibodies to protect against future infections. Until now, it was not known why some plasma cells moved into the bone marrow, while others remained in the blood stream and perished after a few days."
The research team discovered that when the gene that produces the protein Myb was removed, plasma cells were no longer able to move into the bone marrow to provide long-term immunity. "Myb is a type of protein called a transcription factor, which binds to DNA and, in effect, switches genes 'on' or 'off'," Good-Jacobson adds. "We found that if a plasma cell produced Myb at some stage during an immune response, then those plasma cells had the ability to migrate into the bone marrow. If we can understand how to flip the molecular switch in plasma cells and activate Myb production, we might be able to encourage the immune system to create long-term immunity for a range of infections."
Plasma cells are created during an immune response in temporary structures called germinal centres, Dr Good-Jacobson said. "Germinal centres act as a rapid proto-typing facility, improving the design of antibodies to better recognise invading pathogens in the future," she said. "The Myb protein marks the plasma cells that produce high-quality antibodies for preservation."
Tarlinton says the discovery would mean researchers could now search for the trigger of Myb production and find out what genes Myb controls. "Now that we know Myb is critical in creating long-term immunity, we can begin dissecting the pathways it uses to mark plasma cells for storage and the genes involved in migrating to the bone marrow," he says. "Some pathogens, such as malaria, typically trigger the creation of short-lived plasma cells. If we don't create long-lived plasma cells, we don't develop lasting immunity to the disease. If we can trigger the expression of Myb in plasma cells responding to pathogens - either by infection or by immunisation - we might be able to convince the immune system to store these plasma cells in the bone marrow to offer protection against future infections."
The study was funded by the Leukemia Foundation, the Australian Research Council, the National Health and Medical Research Council and the Victorian Government Operational Infrastructure Scheme.
Source: Walter and Eliza Hall Institute
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.